EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

After its $1 billion acquisition by Novartis, Mariana Oncology is expanding its Massachusetts real estate. Biotech's Future - ...

The Democratic primary for public advocate pits Jumaane Williams, the progressive incumbent, against Jenifer Rajkumar, a ...

A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now ...

In response to the proposal presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central ...

As Dr. Geary transitions out of his role, he will continue as a strategic consultant through 2026 to ensure continuity. Ionis ...

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...

With a backdrop of mounting industry disruption and transition, Pharm Exec’s latest listing of the top global biopharma sales ...

The CAR-T Cell Therapy Market is growing rapidly with expanding indications, rising trials, and innovations in solid tumor and autoimmune applications.

Modus, a trusted partner for leading brands like Novartis and Moody's, pairs AI with senior practitioners to drive businesses forward. NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / AI is revol ...